|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1250 GBX | +4.17% |
|
+13.64% | -41.86% |
| 08-10 | Ramsdens agrees takeover; Likewise sees strong August | AN |
| 07-28 | EARNINGS AND TRADING: NYCE International takeover talks fall through | AN |
| Market Cap | 6.28M 7.25M 5.88M 5.36M 10.09M 692M 10.26M 68.98M 26.99M 346M 27.21M 26.61M 1.15B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 11.18M 12.91M 10.47M 9.55M 17.97M 1.23B 18.27M 123M 48.06M 616M 48.45M 47.39M 2.06B | EV / Sales 2026 * |
5.97x | EV / Sales 2027 * | - |
| Free-Float |
90.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Oxford BioDynamics Plc
| 1 day | +4.17% | ||
| 1 week | +13.64% | ||
| Current month | +13.64% | ||
| 1 month | +25.00% | ||
| 3 months | -30.56% | ||
| 6 months | -55.36% | ||
| Current year | -41.86% |
| 1 week | 0.1 |  | 0.14 |
| 1 month | 0.09 | | 0.17 |
| Current year | 0.08 | | 0.34 |
| 1 year | 0.08 | | 0.75 |
| 3 years | 0.08 | | 52 |
| 5 years | 0.08 | | 54 |
| 10 years | 0.08 | | 278.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Compton
CEO | Chief Executive Officer | - | 2026-06-29 |
| Chief Tech/Sci/R&D Officer | 64 | 2007-06-07 | |
Paul Stockdale
DFI | Director of Finance/CFO | - | 2017-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2007-06-07 | |
Paul Stockdale
BRD | Director/Board Member | - | 2017-09-14 |
David Holbrook
BRD | Director/Board Member | 65 | 2019-04-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/10/25 | Free | Founder | 15,000,000 | 0.7663% | ||
| 11/10/25 | Free | Executive/Senior Manager | 15,000,000 | 0.7663% | ||
| 11/10/25 | Free | Chief Operating Officer | 15,000,000 | 0.7663% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.17% | +13.64% | -73.68% | -98.89% | 6.96M | |
| +0.60% | +7.75% | -2.11% | -26.18% | 2.63B | |
| +6.05% | +14.74% | -0.05% | -82.81% | 1.81B | |
| +1.43% | +8.75% | -5.69% | -12.19% | 350M | |
| +1.80% | +5.82% | -44.31% | - | 56.39M | |
| Average | +2.81% | +10.82% | -25.17% | -55.02% | 972.37M | |
| Weighted average by Cap. | +2.71% | +20.79% | -2.19% | -46.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.87M 2.16M 1.75M 1.6M 3.01M 206M 3.06M 20.56M 8.05M 103M 8.11M 7.93M 344M | - |
| Net income | - | - |
| Net Debt | 4.9M 5.66M 4.59M 4.19M 7.88M 540M 8.01M 53.86M 21.07M 270M 21.24M 20.78M 901M | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | GBX 0.1250 | +4.17% | 43,537,322 |
| 26-08-10 | GBX 0.1200 | +9.09% | 72,077,080 |
| 26-08-07 | GBX 0.1100 | +4.76% | 3,695,376 |
| 26-08-06 | GBX 0.1050 | -5.41% | 75,327,569 |
| 26-08-05 | GBX 0.1110 | +5.71% | 26,294,033 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001250GBP
Average target price
0.0100GBP
Spread / Average Target
+700.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OBD Stock
Select your edition
All financial news and data tailored to specific country editions
